reglab/statecodes huggingface dataset:
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 690 - CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE › Subpart I - ISOLATION, QUARANTINE, AND CLOSURE › Section 690.1380 - Physical Examination, Testing and Collection of Laboratory Specimens

Current through Register Vol. 48, No. 28, July 12, 2024
a) The
				Department or certified local health department may order physical examinations
				and tests and collect laboratory specimens as necessary for the diagnosis or
				treatment of individuals in order to prevent the probable spread of a
				dangerously contagious or infectious disease. (Section 2(d) of the
				Act)
b) Persons who are subject to
				physical examination, tests and collection of laboratory specimens shall report
				for physical examinations, tests, and collection of laboratory specimens and
				comply with other conditions of examinations, tests, and collection as the
				Department or certified local health department orders.
c) An individual may refuse to consent to a
				physical examination, test, or collectionof laboratory specimens, but shall
				remain subject to isolation or quarantine, provided that, if those persons are
				isolated or quarantined, they may request a hearing in accordance with this
				Subpart. (Section 2(d) of the Act)
d) An individual shall be given a written
				notice that shall include notice of the following:
1) That the individual may refuse to consent
				to physical examination, test, or collection of laboratory specimens;
2) That if the individual consents to
				physical examination, tests, or collection of laboratory specimens, the results
				of that examination, test, or collection of laboratory specimens may subject
				the individual to isolation or quarantine pursuant to the provisions of this
				Subpart;
3) That if the individual
				refuses to consent to physical examinations, tests, or collection of laboratory
				specimens and that refusal results in uncertainty regarding whether he or she
				has been exposed to or is infected with a dangerously contagious or infectious
				disease or otherwise poses a danger to the public's health, the individual may
				be subject to isolation or quarantine pursuant to the provisions of this
				Subpart; and
4) That if the
				individual refuses to consent to physical examinations, tests, or collection of
				laboratory specimens and becomes subject to isolation and quarantine, he or she
				shall have the right to counsel pursuant to the provisions of this Subpart.
				(Section 2(d) of the Act)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 690 - CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE › Subpart I - ISOLATION, QUARANTINE, AND CLOSURE › Section 690.1385 - Vaccinations, Medications, or Other Treatments

Current through Register Vol. 48, No. 28, July 12, 2024
a) The
				Department or certified local health department may order the administration of
				vaccinations, medications, or other treatments to persons as necessary in order
				to prevent the probable spread of a dangerously contagious or infectious
				disease. (Section 2(e) of the Act)
b) Persons who are required to receive
				treatment, including, but not limited to, vaccination and medication, shall
				comply with other conditions of vaccination, medication, or other treatment as
				the Department or certified local health department orders.
c) An individual may refuse to receive
				vaccinations, medications, or othertreatments, but shall remain subject to
				isolation or quarantine, provided that, if the individual is isolated or
				quarantined, he or she may request a hearing in accordance with this Subpart.
				(Section 2(e) of the Act)
d) An
				individual shall be given a written notice that shall include notice of the
				following:
1) That the individual may refuse
				to consent to vaccinations, medications, or other treatments;
2) That if the individual refuses to receive
				vaccinations, medications, or other treatments, the individual may be subject
				to isolation or quarantine pursuant to the provisions of this Subpart;
				and
3) That if the individual
				refuses to receive vaccinations, medications, or other treatments and becomes
				subject to isolation and quarantine, he or she shall have the right to counsel
				pursuant to the provisions of this Subpart. (Section 2(f) of the Act)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 690 - CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE › Subpart I - ISOLATION, QUARANTINE, AND CLOSURE › Section 690.1390 - Observation and Monitoring

Current through Register Vol. 48, No. 28, July 12, 2024
a) The
				Department or certified local health department may order observation and
				monitoring of persons to prevent the probable spread of a dangerously
				contagious or infectious disease. (Section 2(f) of the Act)
b) Persons who are subject to observation and
				monitoring shall comply with other conditions of observation and monitoring as
				the Department or certified local health department orders.
c) An individual may refuse to undergo
				observation or monitoring, but shall remain subject to isolation or quarantine,
				provided that, if an individual is isolated or quarantined, he or she may
				request a hearing in accordance with this Subpart. (Section 2(f) of the
				Act)
d) An individual shall be
				given a written notice that shall include notice of the following:
1) That the individual may refuse to undergo
				observation and monitoring;
2)
				That, if the individual consents to observation and monitoring, the results of
				that observation and monitoring may subject the individual to isolation or
				quarantine pursuant to the provisions of this Subpart;
3) That if the individual refuses to undergo
				observation or monitoring and that refusal results in uncertainty regarding
				whether the individual has been exposed to or is infected with a dangerously
				contagious or infectious disease or otherwise poses a danger to the public's
				health, the individual may be subject to isolation or quarantine pursuant to
				the provisions of this Subpart; and
4) That, if the individual refuses to undergo
				observation or monitoring and becomes subject to isolation and quarantine, he
				or she shall have the right to counsel pursuant to the provisions of this
				Subpart. (Section 2(f) of the Act)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 690 - CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE › Subpart I - ISOLATION, QUARANTINE, AND CLOSURE › Section 690.1400 - Transportation of Persons Subject to Public Health or Court Order

Current through Register Vol. 48, No. 28, July 12, 2024
The Department or certified local health department shall
				  work with local law enforcement, local emergency medical services and health
				  providers in their jurisdiction to identify appropriate methods of transporting
				  persons to court or to a place for examination, quarantine, isolation, or
				  treatment of the person or group of persons who are subject to a public health
				  order or court order under this Subpart.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 690 - CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE › Subpart I - ISOLATION, QUARANTINE, AND CLOSURE › Section 690.1405 - Information Sharing

Current through Register Vol. 48, No. 28, July 12, 2024
a)
				Whenever a certified local health department learns of a case of a reportable
				illness or health condition, an unusual cluster, or a suspicious event that may
				be the cause of a public health emergency as that term is defined in Section 4
				of the Illinois Emergency Management Agency Act, it shall immediately notify
				the Department, the Illinois Emergency Management Agency, and the appropriate
				State and local law enforcement authorities.
b) Sharing of medical information on persons
				with reportable illnesses or health conditions, unusual disease or symptom
				clusters, or suspicious events between the Department, certified local health
				departments and law enforcement authorities shall be restricted to information
				necessary for the treatment, control of, investigation of, containment of, and
				prevention of a public health emergency, as that term is defined in Section 4
				of the Illinois Emergency Management Act, or for criminal investigation or
				criminal prosecution of or arising out of that matter.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 690 - CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE › Subpart I - ISOLATION, QUARANTINE, AND CLOSURE › Section 690.1410 - Amendment and Termination of Orders

Current through Register Vol. 48, No. 28, July 12, 2024
a) The Department or certified local health
				department that issued the order of isolation, quarantine, or closure shall
				periodically reexamine the reasons upon which the order of isolation,
				quarantine, or closure was based. This reexamination shall occur upon any
				significant change in circumstances or scientific recommendations, but in any
				event must be done at least every 30 days.
b) If, at any time, the Department or
				certified local health department determines that the conditions justifying the
				order of isolation, quarantine, or closure no longer exist, the Department or
				certified local health department shall:
1)
				Immediately discharge the person or group of persons or the owner whose place
				was subject to closure from the order of isolation, quarantine, or closure if
				the order was issued by the Department or certified local health department;
				or
2) File a petition with the
				local circuit court requesting that the person or group of persons be
				discharged and the court order for isolation, quarantine or closure be
				terminated.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 690 - CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE › Subpart I - ISOLATION, QUARANTINE, AND CLOSURE › Section 690.1415 - Penalties

Current through Register Vol. 48, No. 28, July 12, 2024
a) Any person who
				knowingly or maliciously disseminates any false information or report
				concerning the existence of any dangerously contagious or infectious disease in
				connection with the Department or certified local health department's power of
				quarantine, isolation and closure or refuses to comply with a quarantine,
				isolation or closure order is guilty of a Class A misdemeanor. (Section 2(k) of
				the Act)
b) A public health order
				issued by a certified local health department under this Subpart is equivalent
				to, shall be enforced as, and carries the same penalty as an order issued by
				the Department directly.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 690 - CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE › Subpart J - REGISTRIES › Section 690.1500 - Extensively Drug-Resistant Organism Registry

Current through Register Vol. 48, No. 28, July 12, 2024
a) This Section establishes an Extensively
				Drug-Resistant Organism (XDRO) Registry to collect data on persons entering
				health care facilities who have been diagnosed with an XDRO infection. Options
				for treating patients with XDRO infections are often limited, and XDRO
				infections are associated with increased lengths of stay, costs and mortality.
				The Registry is established to protect patients and to stop the spread of
				communicable disease in health care facilities.
b) XDROs to be included in the registry
				include non-duplicative XDROs considered to be of epidemiologic importance due
				to either severity of clinical disease, potential for transmission of genetic
				elements, or opportunities for effective control efforts.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 690 - CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE › Subpart J - REGISTRIES › Section 690.1510 - Entities Required to Submit and Query Information

Current through Register Vol. 48, No. 28, July 12, 2024
a) The Department requires the following
				health care facilities to report patient incident information regarding
				extensively drug-resistant organisms (XDROs):
1) Hospitals;
2) Hospital-affiliated clinical
				laboratories;
3) Independent or
				free-standing laboratories;
4)
				Long-term care facilities;
5)
				Long-term acute care hospitals (LTACHs);
6) Dialysis centers;
7) Specialized mental health rehabilitation
				facilities; and
8) Other high-risk
				health care facilities serving high-risk patients.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 690 - CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE › Subpart J - REGISTRIES › Section 690.1520 - Information Required to be Reported

Current through Register Vol. 48, No. 28, July 12, 2024
a) A facility required to submit XDRO
				information shall report each Non-Duplicative XDRO Isolate, as specified in
				this Section, to the Department.
b)
				The information to be reported shall be provided in a format designated by the
				Department and may be submitted either by direct electronic transmission or
				entry into a website. The information to be reported is divided into four
				subject areas, each containing a particular set of information. The four
				subject areas of the incidence report shall include the following:
1) Patient Data and Address - patient's full
				name (including maiden name, when applicable and available), last four digits
				of the Social Security number (if available), telephone number and residential
				address, including street address, city, county, state and postal
				code;
2) Personal Data - patient's
				birth date, sex, race and ethnicity (if available);
3) Culture Data - specimen collection date,
				specimen source, isolate genus, isolate species, specific carbapenemase name
				(if known), antibiotic resistance criteria for entry into the Registry;
				and
4) Facility Data - facility
				identification number provided by the Department, the medical record number,
				and the date of admission.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 690 - CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE › Subpart J - REGISTRIES › Section 690.1530 - Methods of Reporting XDRO Registry Information

Current through Register Vol. 48, No. 28, July 12, 2024
a) All patients identified at a reporting
				facility with a non-duplicative XDRO are reportable to the Registry within
				seven calendar days after the test result is finalized.
b) A reporting facility may report XDRO
				infections by one of the following methods:
1) Option #1. Electronic Reporting: Health
				care facilities that have the capacity to submit laboratory data electronically
				may use this option.
2) Option #2.
				Manual Entry into a Website: Facilities that do not have the capacity to submit
				laboratory data electronically shall submit the data through a
				Department-approved website.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 690 - CONTROL OF NOTIFIABLE DISEASES AND CONDITIONS CODE › Subpart J - REGISTRIES › Section 690.1540 - Availability of Information

Current through Register Vol. 48, No. 28, July 12, 2024
a) The
				Department will use information in the XDRO Registry for the following
				purposes:
1) To provide appropriate
				information to a physician or institution providing care or treatment to a
				person;
2) To alert health care
				facilities of the admission of a patient with an XDRO infection;
3) To assess the burden of XDROs in health
				care facilities located in Illinois; and
4) To identify clusters or outbreaks
				requiring response efforts for containment of further transmission, including,
				but not limited to, cohorting, isolation, point prevalence surveys, and other
				infection control activities recommended by the CDC based on the clinical
				conditions of patients or residents, XDRO prevalence, and other
				factors.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart A - GENERAL PROVISIONS › Section 691.200 - Incorporated and Referenced Materials

Current through Register Vol. 48, No. 28, July 12, 2024
The following materials are incorporated or referenced in
				  this Part:
a) Illinois Statutes
1) African-American HIV/AIDS Response Act
				[410 ILCS 303 ]
2) AIDS
				Confidentiality Act [410 ILCS 305 ]
3) HIV/AIDS Registry Act [410 ILCS 310
				]
4) Communicable Disease
				Prevention Act [410 ILCS 315 ]
5)
				The Civil Administrative Code of Illinois [20 ILCS 2310 ]
6) Environmental Protection Act [415 ILCS 5
				]
7) Illinois Grant Funds Recovery
				Act [30 ILCS 705 ]
8) Grant
				Accountability and Transparency Act [30 ILCS 708 ]
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart B - AFRICAN-AMERICAN HIV/AIDS RESPONSE ACT GRANTS › Section 691.300 - Eligibility for Grant Award

Current through Register Vol. 48, No. 28, July 12, 2024
In order to be eligible to receive a grant from the Fund, the
				  applicant must meet the definition of an African-American Community Based
				  Organization, as defined in Section
				  691.100.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart B - AFRICAN-AMERICAN HIV/AIDS RESPONSE ACT GRANTS › Section 691.400 - Grant Requirements

Current through Register Vol. 48, No. 28, July 12, 2024
a)
				Grant recipients must comply with all applicable provisions of the
				African-American HIV/AIDS Response Act, AIDS Confidentiality Act, HIV/AIDS
				Registry Act, Communicable Disease Prevention Act, Environmental Protection
				Act, HIV/AIDS Confidentiality and Testing Code, and Control of Sexually
				Transmitted Diseases Code and with the guidelines of the Centers for Disease
				Control and Prevention for HIV prevention, testing and surveillance (see
				Section
				691.200) .
b) Grants shall be awarded for
programs to prevent the transmission of HIV and other programs and
				activities consistent with the purposes of the Act, including, but not limited
				to, preventing and treating HIV/AIDS
and
the creation of an
				HIV/AIDS service delivery system.
(Section 27 of the Act)
c) The grant
funds shall provide
				resources for communities in Illinois to create an HIV/AIDS service delivery
				system that reduces the disparity of HIV infection and AIDS cases between
				African-Americans and other population groups in Illinois that may be impacted
				by the disease
. (Section 27 of the Act)
d) Grant recipients' objectives shall align
				with the following objectives:
1)
Developing, implementing and maintaining a comprehensive, culturally
				sensitive HIV Prevention Plan targeting communities that are identified as
				high-risk in terms of the impact of the disease on
				African-Americans.
2)
Developing, implementing and maintaining a stable HIV/AIDS service
				delivery infrastructure in Illinois communities that will meet the needs of
				African-Americans
statewide.
3)
Developing, implementing, and
				maintaining a statewide HIV/AIDS testing program.
4)
Providing funding for HIV/AIDS
				social and scientific research to improve prevention and
				treatment.
5)
Providing comprehensive technical and other assistance to
				African-American community service organizations that are involved in HIV/AIDS
				prevention and treatment.
6)
Developing, implementing and
				maintaining an infrastructure for African-American community service
				organization to make them less dependent on government
				resources.
7) Effective
				through December 31, 2022,
creating and maintaining at least 17
				one-stop shopping HIV/AIDS facilities across the State.
Effective
				January 1, 2023,
creating, maintaining, or creating and maintaining at
				least one Black-led Center of Excellence HIV Biomedical Resource Hub for every
				$3,000,000 of available funding.
(Section 27 of the
				Act)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart B - AFRICAN-AMERICAN HIV/AIDS RESPONSE ACT GRANTS › Section 691.500 - Application Procedures

Current through Register Vol. 48, No. 28, July 12, 2024
a)
Any organization, public or private, desiring to receive grant funds
				must submit a grant application to
the Department.
Applications for grant funds shall be made on prescribed forms
				developed by
the Department. (Section 4(a) of the Illinois Grant Funds
				Recovery Act).
b) The Department
				will provide written application instructions to potential applicants in an
				electronic format that will be stated in the Notice of Funding
				Opportunity.
c) Completed
				applications shall be returned to the Department electronically as
				directed.
d) All applications shall
				be submitted in the format prescribed by the Department.
e) All applicants shall comply with the
				requirements set forth in the application.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart B - AFRICAN-AMERICAN HIV/AIDS RESPONSE ACT GRANTS › Section 691.600 - Review of Applications

Current through Register Vol. 48, No. 28, July 12, 2024
a)
				Applications will be reviewed by the Department for compliance with the
				requirements of this Part. During the course of its review, the Department may
				contact the applicant for additional information if the information provided is
				incomplete, inconsistent or unclear.
b) Applicants whom the Department determines
				to be not eligible for grant funds will be notified in writing of this
				decision.
c) Distribution of grants
				is dependent on available funding. Available grant funds will be distributed
				based on the applicant's application and compliance with Sections
				691.400 and
				691.500.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart B - AFRICAN-AMERICAN HIV/AIDS RESPONSE ACT GRANTS › Section 691.700 - Allowable Uses of Grant Funds and Reimbursement Procedures and Requirements

Current through Register Vol. 48, No. 28, July 12, 2024
a) Grant awards
				will be issued in an amount not less than $25,000 per annual funding
				cycle.
b) Funds shall be used only
				for the direct cost of administering, operating and maintaining a project or
				service in accordance with the requirements of Section
				691.400.
c) The grant funds may not be used for
				organizational or community-based overhead costs, indirect costs, legal fees or
				levies.
d) Grant funds must be used
				as provided by the guidelines of OMB Circular A-87 for allowable expenditures
				(see Section
				691.200) .
e) Funds shall be used only for the direct
				cost of administering, operating and maintaining a project or service in
				accordance with the requirements of the grant agreement. Examples of direct
				costs that may be allowable under the grant agreement include: personal
				services costs, such as salaries; contractual services costs, such as fees for
				consultants; travel costs for personnel to carry out authorized activities;
				training and education costs; supplies or commodities that are required in the
				operation of a grant project; equipment directly related to the operation of a
				grant project.
f) Grantee shall
				comply with reimbursement procedures and requirements as outlined in the grant
				agreement. The standard grant agreement template can be found at
https://gata.illinois.gov/content/dam/soi/en/web/gata/documents/resource-library/fy23-uniform-grant-agreement.pdf
.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart B - AFRICAN-AMERICAN HIV/AIDS RESPONSE ACT GRANTS › Section 691.800 - Suspension or Termination of Grant Award

Current through Register Vol. 48, No. 28, July 12, 2024
a) The Department has the authority to
				suspend funding or terminate the grant agreement for failure to comply with the
				Act, this Part, or the grant agreement.
b) The grant agreement may be suspended or
				terminated for any of the reasons specified in the grant agreement, and in
				accordance with the procedures outlined in the grant agreement.
c) The grantee is subject to the provisions
				outlined in 44 Ill. Adm. Code
				7000.80
				and
				7000.260
				(Grantee Compliance Enforcement System; Illinois Stop Payment List).
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart B - AFRICAN-AMERICAN HIV/AIDS RESPONSE ACT GRANTS › Section 691.900 - Denial, Suspension, Revocation or Termination of Grant Award

Current through Register Vol. 48, No. 28, July 12, 2024
a) The Director may
				suspend or revoke the grant agreement of a grantee when finding substantial or
				continued failure to comply with the Act, this Part or the grant agreement.
				Except as provided in subsection (b), the Director shall provide notice and an
				opportunity for the grant applicant or grantee to request a hearing before
				executing the denial, suspension, or revocation.
b) If the Director finds that the public
				interest, health, safety, or welfare requires emergency action, then the
				Director may immediately order summary suspension of a grant agreement pending
				proceedings for revocation. The Director's order shall be written and shall
				include the reasons for the findings. The proceedings shall be promptly
				instituted and promptly determined.
c) The notice of denial shall be made by
				regular mail. The notice of suspension or revocation shall be made by certified
				mail or personal service. These notices shall state the reasons for the
				proposed action and shall provide the opportunity to request a hearing. If a
				written hearing request is not received within 10 business days after receipt
				of the notice, then the right to a hearing is deemed waived.
d) A denial or termination due to the General
				Assembly's failure to appropriate funds is not subject to this
				Section.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart B - AFRICAN-AMERICAN HIV/AIDS RESPONSE ACT GRANTS › Section 691.1000 - Grant Funds Recovery

Current through Register Vol. 48, No. 28, July 12, 2024
Grants made under this Part are subject to the Illinois Grant
				  Funds Recovery Act. If a provision of this Part conflicts with a provision of
				  the Illinois Grant Funds Recovery Act, then the provision of the Illinois Grant
				  Funds Recovery Act controls.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart B - AFRICAN-AMERICAN HIV/AIDS RESPONSE ACT GRANTS › Section 691.1100 - Hearings

Current through Register Vol. 48, No. 28, July 12, 2024
The Department's Rules of Practice and Procedure in
				  Administrative Hearings apply to the proceedings conducted under this Part.
				  Where the terms "license" and "licensing" are used in those rules, those terms
				  shall be expanded to include a grant applicant, a grantee awarded funds, and a
				  grant agreement executed under this Part.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart C - TRAINING AND HIV TESTING PROTOCOLS › Section 691.1200 - Training Requirements for HIV Test Counseling

Current through Register Vol. 48, No. 28, July 12, 2024
a) HIV counseling and testing services must
				be administered by persons who have completed a course of training provided or
				approved by the Department.
b)
				Persons providing HIV counseling and testing services shall comply with the
				provisions of the AIDS Confidentiality Act.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart C - TRAINING AND HIV TESTING PROTOCOLS › Section 691.1300 - HIV Testing Protocols

Current through Register Vol. 48, No. 28, July 12, 2024
a) HIV
				antibody testing shall be completed in accordance with Section
				697.100
				of the HIV/AIDS Confidentiality and Testing Code.
b) All persons seeking counseling and HIV
				testing at an HIV testing site operated by a Department funded African-American
				community-based organization shall be offered a rapid HIV Antibody Test. If the
				HIV test counselor determines that rapid HIV antibody testing is not
				appropriate at the time of testing, the person shall be offered the option of
				another HIV antibody test.
c) A
				patient record shall be created for each person tested at an HIV testing site
				operated by a Department funded African-American community-based organization.
				All patient records shall be maintained in accordance with the provisions of
				the AIDS Confidentiality Act.
d) No
				person may order an HIV test without first providing pre-test information and
				receiving the documented informed consent of the subject of the test or the
				subject's legally authorized representative, in accordance with the HIV/AIDS
				Confidentiality and Testing Code.
e) HIV counseling and testing centers shall
				provide counseling to the test subject prior to performing the test. The
				counseling must include, but is not limited to, information about:
1) HIV infection and HIV
				transmission;
2) The difference
				between confidential and anonymous HIV testing;
3) Information about the meaning of the test
				and test results, such as the purpose, potential uses, and limitations of the
				test and test results and the statutory rights to anonymous testing and to
				confidentiality;
4) Information
				about the availability of supplemental testing;
5) The availability of referrals for further
				information or counseling; and
6)
				Methods for prevention of transmission of HIV.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 691 - AFRICAN-AMERICAN HIV/AIDS RESPONSE CODE › Subpart D - REMOVAL AND PROPER DISPOSAL OF HAZARDOUS WASTE › Section 691.1400 - Removal and Proper Disposal of Hazardous Waste

Current through Register Vol. 48, No. 28, July 12, 2024
All Potentially Infectious Medical Waste (PIMW) generated
				  through HIV testing shall be handled and disposed of in a safe and responsible
				  manner. Department funded African-American community-based organizations should
				  contact the local health authority or local waste removal company for the
				  correct disposal method for PIMW. The PIMW shall be placed in containers that
				  are:
a) Rigid;
b) Leak-resistant;
c) Impervious to moisture;
d) Sufficiently strong to prevent tearing or
				bursting under normal conditions of use and handling;
e) Sealed to prevent leakage during
				transport;
f) Puncture-resistant
				for packaging sharps and sharps with residual fluids; and
g) Break-resistant and tightly lidded or
				stoppered for packaging fluids.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 692 - AIDS DRUG ASSISTANCE PROGRAM › Section 692.5 - Definitions

Current through Register Vol. 48, No. 28, July 12, 2024
"AIDS Drug Assistance Program" or "ADAP" means a program that
				provides drugs to prolong the lives of low income persons with Acquired
				Immumodeficiency Syndrome (AIDS) or Human Immunodeficiency Virus (HIV)
				infection who are not eligible under Article V of the Illinois Public Aid Code
				for Medical Assistance. (Section 2310-315(13) of the Civil Administrative Code
				of Illinois)
"CD4 count" means the measurement of the number of CD4 cells in
				a sample of blood, which tells how strong the immune system is and indicates
				the stage of HIV disease.
"Creditable coverage" means coverage of an individual as
				defined in
				45 CFR
				146.113(a)(1) (Public
				Welfare: Rules relating to creditable coverage).
"Department" means the Illinois Department of Public
				Health.
"Extra Help Program" means a federal program that assists very
				low income (less than $1,000/month) Medicare Part D eligible individuals with
				their prescription drug coverage. The program pays Medicare Part D premiums and
				all copayments except $2 and $3 on generic and brand, respectively. The program
				was established by the Patient Protection and Affordable Care Act (
				P.L.
				111-148 ).
"Medicaid" means the State-managed program under the federal
				Social Security Act (
				42 USC
				1396 ) that pays medical care expenses for
				low-income individuals, including those with HIV/AIDS.
"Medicare" means the federal program under the Social Security
				Act (
				42 USC
				1395 ) that pays for certain
health care
expenses
for
people age
65 or older. Enrolled
individuals
must
pay
deductibles
and co-payments.
"Prescription insurance" means insurance paid for or provided
				by an employer, family member or the applicant that covers prescription
				medications.
"Viral load" means a measurement of human immunodeficiency
				virus (HIV) in a sample of blood or other body fluids.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 692 - AIDS DRUG ASSISTANCE PROGRAM › Section 692.6 - Incorporated and Referenced Materials

Current through Register Vol. 48, No. 28, July 12, 2024
The following materials are incorporated or referenced in this
				Part:
a) Illinois Statutes
1) Civil Administrative Code of Illinois [20
			 ILCS 2310 ]
2) Illinois Public Aid
			 Code [305 ILCS 5 ]
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 692 - AIDS DRUG ASSISTANCE PROGRAM › Section 692.10 - Drugs to Prolong the Lives of Non-Medicaid Persons with Acquired Immunodeficiency Syndrome (AIDS) or Human Immunodeficiency Virus (HIV) Infection

Current through Register Vol. 48, No. 28, July 12, 2024
Drugs provided under this Part are paid for on behalf of
				low-income individuals with acquired immunodeficiency syndrome (AIDS) or human
				immunodeficiency virus (HIV).
a)
			 Eligibility requirements. To qualify for services under this Part, a person
			 shall have been enrolled in the AIDS Drug Assistance Program (ADAP) as of June
			 4, 1996, or:
1) Apply to the Department for
			 acceptance for ADAP and comply with all recertification requirements, which
			 occur every six months from the point of enrollment; and
2) Be diagnosed as having AIDS or HIV and be
			 currently receiving HIV care, including having received a viral load test
			 result and CD4 count within the six months prior to the date of the application
			 or recertification.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 692 - AIDS DRUG ASSISTANCE PROGRAM › Section 692.15 - Application Requirements

Current through Register Vol. 48, No. 28, July 12, 2024
Applications for participation in ADAP shall be submitted on
				forms provided by the Department. Information requested on the application will
				include, but not be limited to:
a)
			 Patient information, including marital status, race/ethnicity, pregnancy
			 information, and risk factors;
b)
			 Residency information, including mailing address and prescription address, if
			 different from mailing address;
c)
			 Demographic (name, date of birth, relationship) and income information on
			 household members who qualify as legal dependants to the ADAP applicant, and
			 who may also contribute to the household income, which would affect the federal
			 poverty level for the applicant as defined by ADAP's federal partner, the
			 United States Health Resources and Services Administration (HRSA);
d) Applicant's income information, including,
			 but not limited to:
1) Gross monthly income,
			 from sources such as wages, unemployment compensation, Social Security, Social
			 Security Disability, veterans' pension, veterans' disability, private
			 disability, workers' compensation, temporary assistance for needy families,
			 general assistance, retirement income, child support, alimony or other spousal
			 support, or any/or all other sources of income provided by the
			 applicant;
2) Documentation of
			 income from paycheck stubs, benefit statement, award letter, court order,
			 federal tax return, or other documentation provided by the applicant or
			 available to the Department;
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 692 - AIDS DRUG ASSISTANCE PROGRAM › Section 692.16 - Non-Discrimination

Current through Register Vol. 48, No. 28, July 12, 2024
The Department will ensure that no individual participating in
				any program or activity of ADAP will be discriminated against because of race,
				color, religious belief, political affiliation, sex, sexual orientation,
				national origin or handicap. Pursuant to the requirements of State and federal
				law, the Department will make reasonable accommodations for individuals with
				disabilities.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 692 - AIDS DRUG ASSISTANCE PROGRAM › Appendix A - 2023 Poverty Income Guidelines

Current through Register Vol. 48, No. 28, July 12, 2024
2023 Health and Human Services
						  Poverty Guidelines
Persons in Family
100% Poverty
						  Guideline
Maximum Gross Annual Income ADAP
						  300% Eligibility
1
$14,580
$43,740
2
19,720
59,160
3
24,860
74,580
4
30,000
90,000
5
35,140
105,420
6
40,280
120,840
7
45,420
136,260
8
50,560
151,680
For additional persons, add
5,140
15,420
See: Federal Register: 88 FR 3424, January 19,
						  2023
See 78 Fed. Reg. 5183 (January 24,
				  2013).
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 692 - AIDS DRUG ASSISTANCE PROGRAM › Appendix B - Ryan White HIV/AIDS Treatment Extension Act of 2009 Sliding Fee Scale

Current through Register Vol. 48, No. 28, July 12, 2024
Sliding Fee Scale
Individual/Family
Annual Gross Income
Total Allowable
Annual Charges
Equal to or below the official poverty line
No charges permitted
101 to 200 percent of the official poverty line
5 percent or less of gross income level
201 to 300 percent of the official poverty line
7 percent or less of gross income level
more than 300 percent of the official poverty
						  line
10 percent or less of gross income level
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 693 - CONTROL OF SEXUALLY TRANSMISSIBLE INFECTIONS CODE › Section 693.15 - Incorporated and Referenced Materials

Current through Register Vol. 48, No. 28, July 12, 2024
The following materials are incorporated or referenced in this
				Part:
a Illinois Statutes
1 Illinois Sexually Transmissible Disease
			 Control Act [410 ILCS 325 ]
2
			 Department of Public Health Act [20 ILCS 2305 ]
3 Consent by Minors to Medical Procedures Act
			 [410 ILCS 210 ]
4 AIDS
			 Confidentiality Act [410 ILCS 305 ]
5 Unified Code of Corrections [730 ILCS 5/5-5
			 -3]
6 Hypodermic Syringes and
			 Needles Act [720 ILCS 635 ]
7
			 Criminal Code of 1961 [720 ILCS 5 ]
8 Freedom of Information Act [5 ILCS 140
			 ]
9 Nurse Practice Act [225 ILCS 65
			 ]
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 693 - CONTROL OF SEXUALLY TRANSMISSIBLE INFECTIONS CODE › Section 693.20 - Reportable STIs and Laboratory Results

Current through Register Vol. 48, No. 28, July 12, 2024
a) The following shall be considered
			 reportable STIs:
1) Acquired Immunodeficiency
			 Syndrome (AIDS), as defined by the Centers for Disease Control and Prevention
			 of the United States Public Health Service, in 2008 Revised Surveillance Case
			 Definitions for HIV Infection Among Adults, Adolescents, and Children Aged Less
			 than 18 Months and for HIV Infection and AIDS Among Children Aged 18 Months to
			 13 Years.
2) HIV Infection (see
			 Section
			 693.10 for a
			 definition);
3) Syphilis;
4) Gonorrhea;
5) Chlamydia; and
6) Chancroid.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 693 - CONTROL OF SEXUALLY TRANSMISSIBLE INFECTIONS CODE › Section 693.35 - Fines and Penalties

Current through Register Vol. 48, No. 28, July 12, 2024
a) The
			 Department, after notice and an opportunity for a hearing, may fine any health
			 care professional, laboratory or blood bank that violates Section
			 693.30 of this Part or
			 Section 4 of the Act. The fine shall be $500 for each violation. Based upon the
			 evidence presented at the hearing, fines shall be imposed based upon malicious
			 intent, negligence and incompetence. Following service of a Notice of Violation
			 by the Department, the respondent health care professional, laboratory or blood
			 bank shall have 10 business days in which to request a hearing. All proceedings
			 under this subsection shall be governed by the Department's Practice and
			 Procedure in Administrative Hearings.
b) The Department shall report each violation
			 of Section 4 of the Act or Section
			 693.30 of this Part to
			 the regulatory agency responsible for licensing a health care professional or a
			 laboratory to which these provisions apply. (Section 4(d) of the Act)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 693 - CONTROL OF SEXUALLY TRANSMISSIBLE INFECTIONS CODE › Section 693.45 - Notification of Health Care Contacts

Current through Register Vol. 48, No. 28, July 12, 2024
a) The Department will develop a form letter,
			 which the Department will use to notify health care contacts pursuant to
			 Section
			 693.40
			 of this Part and that will be offered to individuals choosing to self-notify
			 their health care contacts. The letter will include a list of facilities where
			 HIV counseling and testing are available and information about HIV transmission
			 and laboratory tests, and will recommend that the recipient contact his or her
			 personal physician or one of the counseling and testing facilities listed.
1) For contacts who are patients, the letter
			 will identify the type of health care professional with whom the recipient had
			 contact, without naming the specific health care professional.
2) For contacts who are health care
			 professionals, the letter will state that the recipient is believed to have
			 performed an exposure-prone invasive procedure on a patient who has been
			 reported to the Department as a case with HIV, without naming the
			 patient.
3) The letter will also
			 advise the recipient as to applicable confidentiality requirements.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 693 - CONTROL OF SEXUALLY TRANSMISSIBLE INFECTIONS CODE › Section 693.60 - Quarantine and Isolation for Syphilis, Gonorrhea, Chlamydia, HIV and Chancroid

Current through Register Vol. 48, No. 28, July 12, 2024
a) The Department
			 or certified local health department may order a person to be isolated or a
			 place to be quarantined and made off limits to the public to prevent the
			 probable spread of syphilis, gonorrhea, chlamydia, HIV or chanchroid, until
			 such time as the condition can be corrected or the danger to the public health
			 is eliminated or reduced in such a manner that no substantial danger to the
			 public's health any longer exists. (Section 7(a) of the Act) The determination
			 that action is required shall be based on the following:
1) The Department or certified local health
			 department has reason to believe that a person infected with syphilis,
			 gonorrhea, chlamydia, HIV or chanchroid is noncompliant and is likely to spread
			 syphilis, gonorrhea, chlamydia, HIV or chanchroid if not detained for
			 isolation;
2) The Department or the
			 certified local health department has reason to believe that a place where
			 there is significant sexual activity is likely to contribute to the spread of
			 syphilis, gonorrhea, chlamydia, HIV or chanchroid if quarantine procedures are
			 not initiated; and
3) The
			 Department or the certified local health department has first made efforts,
			 which shall be documented, to obtain voluntary compliance with requests for
			 medical examination, testing, treatment and counseling of a noncompliant person
			 infected with syphilis, gonorrhea, chlamydia, HIV or chanchroid or the owner of
			 a place where there is significant sexual activity that is likely to contribute
			 to the spread of syphilis, gonorrhea, chlamydia, HIV or chanchroid.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 693 - CONTROL OF SEXUALLY TRANSMISSIBLE INFECTIONS CODE › Section 693.100 - Confidentiality

Current through Register Vol. 48, No. 28, July 12, 2024
a)
All
			 information and records held by the Department and
local health
			 departments or designated agents
relating to known or suspected cases
			 of
STIs
shall be strictly confidential and exempt from
			 inspection and copying under the Freedom of Information Act. The Department
			 and
local health departments or designated agents
shall not
			 disclose information and records held by them relating to known or suspected
			 cases of
STIs
publicly or in any action of any kind in any
			 court or before any tribunal, board or agency.
(Section 8(a) of the
			 Act)
b) Information and records
			 contained in databases maintained by the Department, certified local health
			 departments, or designated agents containing the information described in
			 subsection (a) shall not be released for the purposes of matching with other
			 State agency databases, except to the Illinois Department of Healthcare and
			 Family Services for the sole purpose of treatment of a person living with HIV
			 subject to state, federal and tribal confidentiality statutes and
			 regulations.
c)
The
			 information shall not be released or made public
by the Department,
			 local health departments or designated agents, or by a court or parties to a
			 lawsuit upon revelation by subpoena, or
by a court conducting
			 proceedings authorized by Section 6(c) of
the
Act, except that
			 release of the information may be made under the following
			 circumstances
:
1)
When made
			 with the consent of all persons to which the information applies
(Section 8(a)(1) of the Act);
2)
When made for statistical purposes and medical or epidemiologic
			 information is summarized so that no person can be identified and no names are
			 revealed
(Section 8(a)(2) of the Act);
3)
When made to medical
			 personnel
, the Department, local health departments or designated
			 agents for care and treatment purposes, including for the purposes of ensuring
			 that medical providers can attempt to re-engage persons with HIV in care and to
			 provide partner services
, appropriate State agencies
expressly
			 charged in the Act and this Part with enforcement of the provisions of the Act,
or courts of appropriate jurisdiction to enforce the provisions
			 of
the
Act and
this Part (Section 8(a)(3) of the
			 Act);
4) When authorized by 77 Ill.
			 Adm. Code
			 697.210
			 (HIV/AIDS Confidentiality and Testing Code);
5) When authorized by the AIDS
			 Confidentiality Act.